Valneva SE ADR
Biotechnology
Healthcare
VALN
132 M shares
NASDAQ US
traded
25 Jun 2025
listed
no
open
5.71
52 week high
8.33
high
5.72
52 week low
3.69
previous Close
5.60
P/E ratio
market cap
340 M
div yield
0
net incoming
-9.24 M
62.96 %
net profit margin
-20.16 %
45.00 %
operating incoming
-12.45 M
42.22 %
net change in cash
24.92 M
155.10 %
cash on hand
156 M
18.96 %
cost of revenue
25.68 M
9.42 %
top